393 related articles for article (PubMed ID: 11339901)
1. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus vectors using human and simian immunodeficiency virus elements.
White SM; Renda M; Nam NY; Klimatcheva E; Zhu Y; Fisk J; Halterman M; Rimel BJ; Federoff H; Pandya S; Rosenblatt JD; Planelles V
J Virol; 1999 Apr; 73(4):2832-40. PubMed ID: 10074131
[TBL] [Abstract][Full Text] [Related]
3. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay.
Rizvi TA; Schmidt RD; Lew KA; Keeling ME
Virology; 1996 Aug; 222(2):457-63. PubMed ID: 8806531
[TBL] [Abstract][Full Text] [Related]
4. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
5. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
[TBL] [Abstract][Full Text] [Related]
6. Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.
Guan Y; Whitney JB; Detorio M; Wainberg MA
J Virol; 2001 May; 75(9):4056-67. PubMed ID: 11287555
[TBL] [Abstract][Full Text] [Related]
7. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.
Schnell T; Foley P; Wirth M; Münch J; Uberla K
Hum Gene Ther; 2000 Feb; 11(3):439-47. PubMed ID: 10697118
[TBL] [Abstract][Full Text] [Related]
8. Development of second- and third-generation bovine immunodeficiency virus-based gene transfer systems.
Matukonis M; Li M; Molina RP; Paszkiet B; Kaleko M; Luo T
Hum Gene Ther; 2002 Jul; 13(11):1293-303. PubMed ID: 12162812
[TBL] [Abstract][Full Text] [Related]
9. Production of lentiviral vectors for transducing cells from the central nervous system.
Li M; Husic N; Lin Y; Snider BJ
J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
[TBL] [Abstract][Full Text] [Related]
10. Helper plasmids for production of HIV-1-derived vectors.
Fuller M; Anson DS
Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
[TBL] [Abstract][Full Text] [Related]
11. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
D'Costa J; Brown HM; Kundra P; Davis-Warren A; Arya SK
J Gen Virol; 2001 Feb; 82(Pt 2):425-434. PubMed ID: 11161282
[TBL] [Abstract][Full Text] [Related]
13. A new-generation stable inducible packaging cell line for lentiviral vectors.
Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
[TBL] [Abstract][Full Text] [Related]
14. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
15. Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system.
Nakajima T; Nakamaru K; Ido E; Terao K; Hayami M; Hasegawa M
Hum Gene Ther; 2000 Sep; 11(13):1863-74. PubMed ID: 10986559
[TBL] [Abstract][Full Text] [Related]
16. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.
Johnston JC; Gasmi M; Lim LE; Elder JH; Yee JK; Jolly DJ; Campbell KP; Davidson BL; Sauter SL
J Virol; 1999 Jun; 73(6):4991-5000. PubMed ID: 10233961
[TBL] [Abstract][Full Text] [Related]
17. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.
Mangeot PE; Nègre D; Dubois B; Winter AJ; Leissner P; Mehtali M; Kaiserlian D; Cosset FL; Darlix JL
J Virol; 2000 Sep; 74(18):8307-15. PubMed ID: 10954529
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral vectors for gene therapy of HIV-1 infection.
Mautino MR
Curr Gene Ther; 2002 Feb; 2(1):23-43. PubMed ID: 12108972
[TBL] [Abstract][Full Text] [Related]
19. Reduced mobilization of Rev-responsive element-deficient lentiviral vectors.
Lucke S; Grunwald T; Uberla K
J Virol; 2005 Jul; 79(14):9359-62. PubMed ID: 15994835
[TBL] [Abstract][Full Text] [Related]
20. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.
Srinivasakumar N; Schuening FG
J Virol; 1999 Nov; 73(11):9589-98. PubMed ID: 10516068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
